We are live on
!
Find out more
FLC
Fifth Lane Capital Portfolio holdings
AUM
$1.63M
1-Year Est. Return
7.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.5%
1 Year Est. Return
+7.5%
3 Year Est. Return
+79.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$32.4M
(+33%)
Cap. Flow
+$37.9M
Cap. Flow
% of AUM
28.69%
Top 10 Holdings %
Top 10 Hldgs %
55.61%
Holding
195
New
90
Increased
16
Reduced
10
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NWAX.U
New America Acquisition I Corp Units
NWAX.U
|
+$4.42M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$3.94M |
| 3 |
CEPF
Cantor Equity Partners IV
CEPF
|
+$3.84M |
| 4 |
BEAG
Bold Eagle Acquisition Corp
BEAG
|
+$2.63M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$2.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CFND
C1 Fund Inc
CFND
|
+$4.84M |
| 2 |
PCAP
ProCap Acquisition Corp
PCAP
|
+$3.43M |
| 3 |
CAEP
Cantor Equity Partners III
CAEP
|
+$3.24M |
| 4 |
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
|
+$3M |
| 5 |
WENN
Wen Acquisition Corp
WENN
|
+$2.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.28% |
| 2 | Healthcare | 8.82% |
| 3 | Technology | 7.85% |
| 4 | Consumer Discretionary | 2.45% |
| 5 | Communication Services | 1.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLY
76
Firefly Aerospace
FLY
$4.39B
| $249K | 0.19% |
+11,150
| New | +$258K |
|
77
Sable Offshore Corp
SOC
$911M
| $248K | 0.19% |
27,500
+12,490
| +83% | +$118K |
|
78
Synopsys
SNPS
$79.7B
| $235K | 0.18% |
+500
| New | +$222K |
|
79
CALL
Cogent Communications
CCOI
$508M
| $216K | 0.16% |
+10,000
| New | +$295K |
|
80
CRISPR Therapeutics
CRSP
$5.17B
| $210K | 0.16% |
+4,000
| New | +$240K |
|
81
PUT
Core Scientific
CORZ
$6.75B
| $182K | 0.14% |
+12,500
| New | +$218K |
|
|
VISN
82
Vistance Networks Inc
VISN
$2.52B
| $181K | 0.14% |
10,000
-5,000
| -33% | -$86.2K |
|
83
CALL
Rocket Lab Corp
RKLB
$51.8B
| $174K | 0.13% |
+2,500
| New | +$143K |
|
84
Ocular Therapeutix
OCUL
$2.02B
| $174K | 0.13% |
14,358
-2,642
| -16% | -$32.1K |
|
|
85
PUT
Ocular Therapeutix
OCUL
$2.02B
| $174K | 0.13% |
+14,300
| New | +$174K |
|
86
KNOT Offshore Partners
KNOP
$366M
| $167K | 0.13% |
+16,145
| New | +$156K |
|
87
CALL
Prenetics Global
PRE
$310M
| $158K | 0.12% |
+10,000
| New | +$146K |
|
88
CALL
Alight
ALIT
$407M
| $146K | 0.11% |
+3,750
| New | +$187K |
|
89
Chemours
CC
$2.37B
| $118K | 0.09% |
+10,000
| New | +$128K |
|
|
90
PUT
Chemours
CC
$2.37B
| $118K | 0.09% |
+10,000
| New | +$128K |
|
91
PUT
Crinetics Pharmaceuticals
CRNX
$8.92B
| $116K | 0.09% |
+2,500
| New | +$111K |
|
92
PUT
Silicon Motion
SIMO
$8.68B
| $92.7K | 0.07% |
+1,000
| New | +$91.8K |
|
93
CALL
Microvision
MVIS
$78.9M
| $83K | 0.06% |
+6,667
| New | +$106K |
|
94
CALL
NextDecade
NEXT
$1.78B
| $79K | 0.06% |
+15,000
| New | +$89.5K |
|
|
BEAG
95
Bold Eagle Acquisition Corp
BEAG
$335M
| $78.9K | 0.06% |
+246,654
| New | +$2.63M |
|
96
CALL
Full House Resorts
FLL
$89M
| $78.3K | 0.06% |
+30,000
| New | +$80.6K |
|
97
CALL
Prime Medicine
PRME
$559M
| $70.8K | 0.05% |
+20,400
| New | +$90.7K |
|
98
Purple Innovation
PRPL
$41.7M
| $69K | 0.05% |
4,000
-979
| -20% | -$19.5K |
|
|
DCH
99
CALL
Dauch Corp
DCH
$1.51B
| $64.1K | 0.05% |
+10,000
| New | +$62.2K |
|
100
SAB Biotherapeutics
SABS
$355M
| $56.1K | 0.04% |
+15,000
| New | +$49.4K |
|
Similar funds
DILIH
DF
HGCK
SH
SCM
BPM
HB
SI
Fifth Lane Capital's Q4 2025 Portfolio in Review
As of Q4 2025, Fifth Lane Capital held 195 positions worth $132M, up 33% from $99.5M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Fifth Lane Capital deployed $37.9M of net new capital in Q4 2025, opening 90 new positions and adding to 16 existing holdings. Its largest new stake was New America Acquisition I Corp Units: 425,500 shares worth $4.43M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 40% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Cantor Equity Partners II, an estimated $1.79M trimmed.
- Fifth Lane Capital's largest Q4 2025 buy was New America Acquisition I Corp Units: 425,500 shares worth $4.43M.
- Fifth Lane Capital added most to Cantor Equity Partners IV in Q4 2025, an estimated $3.84M increase.
- Fifth Lane Capital's biggest Q4 2025 reduction was Cantor Equity Partners II, cutting an estimated $1.79M.
- Fifth Lane Capital fully exited C1 Fund Inc in Q4 2025, selling an estimated $4.84M.
- Fifth Lane Capital's ten largest holdings make up 56% of its $132M portfolio in Q4 2025.
- Fifth Lane Capital opened 90 new positions and closed 77 in Q4 2025.
- Fifth Lane Capital's portfolio value rose 33% quarter-over-quarter to $132M.
Based on Fifth Lane Capital's 13F filing for Q4 2025, filed 13 Feb 2026.